NOT FOR DISTRIBUTION
Header cover image

Market Cap

€253.1m

Last Updated

2021/05/18 01:10 UTC

Data Sources

Company Financials +

Executive Summary

Pihlajalinna Oyj provides social and healthcare services for private persons, companies, insurance companies, municipalities, and hospital districts in Finland. More Details


Snowflake Analysis

Solid track record and good value.

Share Price & News

How has Pihlajalinna Oyj's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: Insufficient data to determine PIHLIh's volatility over the past 3 months.

Volatility Over Time: Insufficient data to determine PIHLIh's volatility change over the past year.


Market Performance


7 Day Return

0%

PIHLIh

4.4%

GB Healthcare

0.2%

GB Market


1 Year Return

-20.4%

PIHLIh

50.5%

GB Healthcare

22.8%

GB Market

Return vs Industry: PIHLIh underperformed the UK Healthcare industry which returned 50.5% over the past year.

Return vs Market: PIHLIh underperformed the UK Market which returned 22.8% over the past year.


Shareholder returns

PIHLIhIndustryMarket
7 Day0%4.4%0.2%
30 Day-1.2%5.7%0.1%
90 Dayn/a14.6%5.1%
1 Year-19.0%-20.4%52.6%50.5%28.3%22.8%
3 Year1.5%-1.2%-10.0%-14.4%9.4%-3.1%
5 Year-28.6%-32.0%-15.1%-21.1%47.0%19.3%

Long-Term Price Volatility Vs. Market

How volatile is Pihlajalinna Oyj's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Pihlajalinna Oyj undervalued compared to its fair value and its price relative to the market?

46.0%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: PIHLIh (€11.66) is trading below our estimate of fair value (€21.6)

Significantly Below Fair Value: PIHLIh is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: PIHLIh is good value based on its PE Ratio (21x) compared to the UK Healthcare industry average (40.9x).

PE vs Market: PIHLIh is good value based on its PE Ratio (21x) compared to the UK market (25.6x).


Price to Earnings Growth Ratio

PEG Ratio: PIHLIh is poor value based on its PEG Ratio (2.5x)


Price to Book Ratio

PB vs Industry: PIHLIh is overvalued based on its PB Ratio (2.2x) compared to the GB Healthcare industry average (2.1x).


Future Growth

How is Pihlajalinna Oyj forecast to perform in the next 1 to 3 years based on estimates from 4 analysts?

8.4%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: PIHLIh's forecast earnings growth (8.4% per year) is above the savings rate (0.9%).

Earnings vs Market: PIHLIh's earnings (8.4% per year) are forecast to grow slower than the UK market (17.7% per year).

High Growth Earnings: PIHLIh's earnings are forecast to grow, but not significantly.

Revenue vs Market: PIHLIh's revenue (3.5% per year) is forecast to grow slower than the UK market (5.3% per year).

High Growth Revenue: PIHLIh's revenue (3.5% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: PIHLIh's Return on Equity is forecast to be low in 3 years time (14.9%).


Past Performance

How has Pihlajalinna Oyj performed over the past 5 years?

1.7%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: PIHLIh has high quality earnings.

Growing Profit Margin: PIHLIh's current net profit margins (2.3%) are higher than last year (0.6%).


Past Earnings Growth Analysis

Earnings Trend: PIHLIh's earnings have grown by 1.7% per year over the past 5 years.

Accelerating Growth: PIHLIh's earnings growth over the past year (268.1%) exceeds its 5-year average (1.7% per year).

Earnings vs Industry: PIHLIh earnings growth over the past year (268.1%) exceeded the Healthcare industry 1.3%.


Return on Equity

High ROE: PIHLIh's Return on Equity (10.2%) is considered low.


Financial Health

How is Pihlajalinna Oyj's financial position?


Financial Position Analysis

Short Term Liabilities: PIHLIh's short term assets (€108.2M) do not cover its short term liabilities (€142.5M).

Long Term Liabilities: PIHLIh's short term assets (€108.2M) do not cover its long term liabilities (€190.3M).


Debt to Equity History and Analysis

Debt Level: PIHLIh's debt to equity ratio (79.1%) is considered high.

Reducing Debt: PIHLIh's debt to equity ratio has increased from 32.1% to 79.1% over the past 5 years.

Debt Coverage: PIHLIh's debt is well covered by operating cash flow (39%).

Interest Coverage: PIHLIh's interest payments on its debt are well covered by EBIT (6.4x coverage).


Balance Sheet


Dividend

What is Pihlajalinna Oyj current dividend yield, its reliability and sustainability?

1.79%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: PIHLIh's dividend (1.79%) is higher than the bottom 25% of dividend payers in the UK market (1.39%).

High Dividend: PIHLIh's dividend (1.79%) is low compared to the top 25% of dividend payers in the UK market (4.12%).


Stability and Growth of Payments

Stable Dividend: PIHLIh has been paying a dividend for less than 10 years and during this time payments have been volatile.

Growing Dividend: PIHLIh's dividend payments have increased, but the company has only paid a dividend for 4 years.


Current Payout to Shareholders

Dividend Coverage: With its reasonably low payout ratio (37.6%), PIHLIh's dividend payments are well covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: PIHLIh's dividends in 3 years are forecast to be well covered by earnings (32.1% payout ratio).


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

2.0yrs

Average management tenure


CEO

Joni Raimo Aaltonen (50 yo)

3.42yrs

Tenure

€433,000

Compensation

Mr. Joni Raimo Mikael Aaltonen has been Chief Executive Officer of Pihlajalinna Oyj since December 11, 2017 and has been its Chairman of the Management Team since August 15, 2019. He was Director of VMP Oy...


CEO Compensation Analysis

Compensation vs Market: Joni Raimo's total compensation ($USD526.12K) is about average for companies of similar size in the UK market ($USD725.19K).

Compensation vs Earnings: Joni Raimo's compensation has increased by more than 20% in the past year.


Leadership Team

Experienced Management: PIHLIh's management team is considered experienced (2 years average tenure).


Board Members

Experienced Board: PIHLIh's board of directors are not considered experienced ( 2.6 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Pihlajalinna Oyj's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Pihlajalinna Oyj
  • Ticker: PIHLIh
  • Exchange: BATS-CHIXE
  • Founded: 2001
  • Industry: Health Care Services
  • Sector: Healthcare
  • Market Cap: €253.055m
  • Shares outstanding: 22.59m
  • Website: https://www.pihlajalinna.fi

Number of Employees


Location

  • Pihlajalinna Oyj
  • Kehräsaari B
  • Tampere
  • Pirkanmaa
  • 33200
  • Finland

Listings


Biography

Pihlajalinna Oyj provides social and healthcare services for private persons, companies, insurance companies, municipalities, and hospital districts in Finland. It offers general practitioner and medical s...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/05/18 01:10
End of Day Share Price2021/05/06 00:00
Earnings2021/03/31
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.